2024-11-17 14:56:00
To further expand the global footprint of its groundbreaking health and wellness applications, Canada-based Myant Corp., a leading provider of advanced healthcare materials, today announced the acquisition of Nanoleq and Osmotex, two leading textile computing companies Based in Switzerland. Zurich has been selected as the headquarters for Myant’s EU and EMEA expansion. These acquisitions will add valuable talent to the company and further consolidate Myant’s leadership position in textile technology. By entering the market and expanding into Europe, Myant is realizing its goal of becoming a global leader in advanced healthcare materials and setting a new standard for connecting people with people and technology.
Nanoleq: a leading Swiss company specializing in smart textiles and biosensor technologies
This strategic acquisition supports Myant’s goal of advancing the future of connected health by integrating Nanoleq’s advanced sensing capabilities into its growing medical device portfolio.
Both companies have a vision to shift the paradigm of healthcare towards prevention and help people by enabling long-term monitoring through textile computer interfaces and clinical data beyond the hospital into the home. Nanoleq’s innovative work in the development of elastic electrical cables, dry electrodes and biosensing technologies is particularly evident in the flagship model Oxa. Oxa allows users to monitor their respiratory function, ECG, heart rate variability (HRV) and stress levels using its state-of-the-art sensor system and receive real-time feedback on their vital signs to improve their physical and mental well-being.
“It is with great enthusiasm that we welcome Nanoleq to the Myant Group,” said Tony Chahine, CEO of Myant. “This acquisition is a critical milestone in our journey to transform healthcare by integrating intelligence into the fabric of everyday life. Health is at the heart of a productive life, and Myant is now ready to further advance the development of innovative personalized medical solutions that enable individuals to proactively monitor their health. The Nanoleq team shares our vision and will support our efforts European and European markets to enter the Middle East will continue to accelerate.”
“Very few companies have succeeded in producing reliable, medically safe, intelligent textiles. Myant’s acquisition of Nanoleq therefore marks an exciting new chapter for us and will help us to significantly scale our activities,” comments Vincent Martinez, CEO at Nanoleq. “The combination of Nanoleq’s expertise in electrically conductive silicones for biosensing With Myant’s medical expertise, this acquisition is a logical step. Both companies agree that our healthcare model is outdated. People need to be empowered to learn about their health before they get sick. All members of our society benefit from improved prevention.
Osmotex: advanced technologies for moisture and fluid management in textiles and medicine
Myant also acquired the technologies of the Swiss deep tech company Osmotex after a joint venture phase. These technologies enable precise control of moisture and particles in individual microchannels as well as in membranes and textiles with billions of such channels or pores.
For textiles and garments, the technology offers an “electronically controlled breathable membrane” that can withstand human sweat rates in the most extreme conditions. This innovation represents a breakthrough for protective clothing and first aid clothing. It acts like a second skin and increases the physiological comfort, performance and safety of the wearer.
In the medical field, Osmotex fabrics will similarly be used as a second skin for optimal wound healing and as next-generation drug delivery systems. Diagnostic applications through the collection, separation and analysis of liquids are also being developed.
“The Osmotex technology is a milestone in the field of moisture and fluid management,” reports Tony Chahine, CEO at Myant. “The technology acts like a second skin and directly influences the physiological and microclimatic conditions of the wearer. Whether in intelligent wound dressings for a rapid healing or in firefighter uniforms to avoid dangerous heat exposure – it removes the limitations of current variants that extract moisture directly from the air, opening up further possibilities, with significant potential for energy savings and reduction of material wear.”
“With Myant, we are now able to maximize the benefits of our technologies,” explains Trond Heldal, CEO of Myant Swiss and former CEO of Osmotex. “We have developed a unique solid-state pump technology based on state-of-the-art materials science and technology “In Myant, we have gained an equally unique partner who covers the value chain from its 17,000 square meter state-of-the-art materials laboratories through manufacturing to integration into a variety of finished products and services.”
About Myant Corp
Myant’s goal is to enable and improve quality of life for everyone. We leverage advances in AI, medicine and advanced materials to promote health, safety, connection and confidence at every stage of life.
Myant is leading a new era of evolution in which AI guardians enhance human capabilities using textile interfaces that function like a connected second skin. Made from groundbreaking modern materials, this second skin blends naturally into our everyday lives and sets new standards for seamless interaction with the digital world.
From birth to old age, AI guardians enrich our daily lives, promote our well-being, keep us safe, redefine how we connect with society, and enable universal access to the best possible care at all times.
In 2024, Myant expanded into the EU with significant growth and brought on world-renowned AI scientist Dr. Xin Gao on board as Chief AI Officer.
For more information, see www.myant.ca.
Information about Nanoleq
Nanoleq is a leading Swiss company for state-of-the-art, flexible and elastic electrical connections, dry electrodes and biosensor technologies. Its flagship product, Oxa, is a smart wearable that tracks respiratory health, ECG, heart rate variability and other physiological markers, providing actionable data on health and well-being.
For more information, see www.nanoleq.com.
Information about Osmotex
Osmotex, a Swiss technology company, has developed and patented innovative technologies for the controlled transport of moisture in micropores, membranes and textiles. The product range includes microfluidic pumps for life sciences, wound care and medical applications as well as air-conditioned clothing for sports. These innovations were developed over several years in close collaboration with leading Swiss universities and research institutes and are protected by a solid patent portfolio.
Consumer Electronic Show (CES) 2025
From January 7-10, 2025, Myant will be at booth 53618 at the Venetian Expo & Convention Center, 201 Sands Ave. in Las Vegas, NV 89169, USA.
1731867927
#Myant #Acquires #Nanoleq #Osmotex #Technologies #Strengthening #Leadership #Advanced #Materials #Textile
How will Myant Corp.’s advancements in wearable technology impact health management and wellness in the coming years?
**Interview with Tony Chahine, CEO of Myant Corp.**
**Editor:** Thank you for joining us today, Tony. Myant recently announced some significant acquisitions. Can you tell us about the strategic importance of acquiring Nanoleq and Osmotex for Myant?
**Tony Chahine:** Thank you for having me. These acquisitions are pivotal for Myant as we look to expand our footprint in Europe and EMEA. Nanoleq brings advanced sensing capabilities with its innovative smart textiles and biosensor technologies, while Osmotex enhances our offerings in moisture and fluid management. Together, these companies strengthen our position as leaders in textile technology and align perfectly with our mission to transform healthcare by integrating technology into the fabric of daily life.
**Editor:** What specific advancements will Nanoleq’s technologies bring to your product portfolio?
**Tony Chahine:** Nanoleq’s expertise in elastic electrical cables and biosensing technologies, evident in products like the Oxa, will allow us to integrate long-term health monitoring seamlessly into everyday lives. Users can track vital signs and receive real-time feedback, enabling proactive health management rather than reactive healthcare. We believe this will fundamentally shift the paradigm toward prevention-focused healthcare.
**Editor:** And what about Osmotex? How do their technologies contribute to Myant’s vision?
**Tony Chahine:** Osmotex’s innovations in moisture and fluid management are a game-changer. Their electronically controlled breathable membranes can significantly enhance physiological comfort and safety, from protective clothing for firefighters to advanced wound healing applications in healthcare. This technology is all about making textiles act as a ‘second skin,’ which is crucial for both performance and recovery.
**Editor:** You mentioned expanding into Europe and the Middle East. How does establishing a headquarters in Zurich play into this strategy?
**Tony Chahine:** Zurich is a hub for innovation in Europe, particularly in healthcare and technology sectors. By setting up our EU and EMEA headquarters here, we position ourselves at the heart of a vibrant ecosystem of research, technology, and collaboration. This strategic location will facilitate partnerships and enhance our ability to bring our groundbreaking health solutions to more people.
**Editor:** What is your ultimate vision for Myant Corp. in the next few years?
**Tony Chahine:** Our vision is ambitious but clear: we want to empower people to take charge of their health through advanced wearable technology that integrates naturally into their lives. We envision a future where our textile interfaces not only connect users to their health data but also enhance their overall well-being and quality of life at every stage. With these acquisitions, we are firmly on that path.
**Editor:** Thank you, Tony. It sounds like Myant is embarking on an exciting journey in the health and wellness space!
**Tony Chahine:** Absolutely! We’re thrilled about the possibilities ahead and the impact we can make on global health. Thank you for having me.
